Atect Corp operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Atect Corp with three other
pharmaceutical manufacturers in Asia:
Hester Pharmaceuticals Limited
sales of 1.36 billion Indian Rupees [US$20.00 million]
(1.25 billion Indian Rupees [US$18.43 million]
Ina Research Incorporation
(2.43 billion Japanese Yen [US$21.90 million]
Atect Corp reported sales of ¥2.67 billion (US$24.10 million)
March of 2018.
increase of 7.5%
versus 2017, when the company's sales were ¥2.48 billion.
This was the third consecutive year of growth at Atect Corp.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Atect Corp had sales
of ¥2.50 billion.